Home > Insider Trading > Filing (0001127602-23-020997)

Filing Details

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1703647	Frequency Therapeutics Inc.	FREQ	Pharmaceutical Preparations (2834)	472324450

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1785299	R. Christopher Loose	C/O Frequency Therapeutics, Inc. 75 Hayden Ave, Suite 300 Lexington MA 02421	Chief Scientific Officer	No	Yes	No	No

Reported Non-Derivative Transactions

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Common Stock	Disposition	2023-07-17	1,415	$0.67	196,037	No	4	S	Direct
Common Stock	Disposition	2023-07-18	1,484	$0.56	194,553	No	4	S	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	S	Direct
No	4	S	Direct

Footnotes

Represents a portion of the shares required to be sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of the restricted stock units pursuant to a Rule 10b5-1 trading plan entered into on March 22, 2022 and does not represent discretionary trades by the Reporting Person.
This transaction was executed in multiple trades through a broker-dealer at prices ranging from $0.60 to $0.71. The price reported in this column reflects the weighted average sales price. Upon request, the reporting person will provide to the SEC staff full information regarding the number of Shares sold at each price.
This transaction was executed in multiple trades through a broker-dealer at prices ranging from $0.55 to $0.56. The price reported in this column reflects the weighted average sales price. Upon request, the reporting person will provide to the SEC staff full information regarding the number of Shares sold at each price.